Insider · CIK 0001747716

Lawley Lori D

Reports to the SEC for 1 company · AMES, IA

sec.gov

Transactions

Companies

Filings

CIK

0001747716

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−12.3K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−21.3K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−25K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−12K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−1,282 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−4,628 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10.6K sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,776 sh	—	—	0
2024-08-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−229 sh	$1.79	−$409.91	12,284
2024-04-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+1,000 sh	$2.84	+$2,840	12,787
2024-04-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−274 sh	$2.84	−$778.16	12,513
2024-04-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+12K sh	—	—	12,000
2024-02-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−215 sh	$3.01	−$647.15	11,787
2023-08-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−229 sh	$3.28	−$751.12	11,502
2023-04-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−274 sh	$3.31	−$906.94	11,231
2023-02-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+1,000 sh	$3.52	+$3,520	11,619
2023-02-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−114 sh	$3.52	−$401.28	11,505
2023-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+12K sh	—	—	12,000
2022-08-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−229 sh	$8.17	−$1,870.93	10,119
2022-04-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−274 sh	$9.23	−$2,529.02	9,848
2022-02-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+1,000 sh	$10.02	+$10K	10,187
2022-02-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−65 sh	$10.02	−$651.3	10,122
2022-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+12K sh	—	—	12,000
2021-08-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+3,750 sh	—	—	9,187
2021-08-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+21.3K sh	—	—	21,250
2021-04-01	LUMOS PHARMA, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−274 sh	$12.25	−$3,356.5	5,437
2021-02-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+869 sh	—	—	5,711
2021-02-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+10.6K sh	—	—	10,625
2020-04-01	LUMOS PHARMA, INC.A Award	Chief Financial Officer	AAward	+4,500 sh	—	—	4,842
2020-04-01	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+1,633 sh	—	—	1,633
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+868 sh	—	—	868
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,000 sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+472 sh	—	—	472
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+98 sh	—	—	98
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+98 sh	—	—	98
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−3,334 sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+1,111 sh	—	—	1,111
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+487 sh	—	—	487
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+70 sh	—	—	70
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−2,352 sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+115 sh	—	—	115
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+311 sh	—	—	311
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+360 sh	—	—	360
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	—	—	0
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+729 sh	—	—	729
2019-07-31	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+3,021 sh	—	—	3,021

Recent filings

Accepted (ET)
Dec 134
Lawley Lori D0001126234-24-000112
SEC(opens sec.gov)
Aug 54
Lawley Lori D0001126234-24-000092
SEC(opens sec.gov)
Apr 34
Lawley Lori D0001126234-24-000038
SEC(opens sec.gov)
Feb 54
Lawley Lori D0001126234-24-000014
SEC(opens sec.gov)
Aug 34
Lawley Lori D0001126234-23-000084
SEC(opens sec.gov)
Apr 44
Lawley Lori D0001126234-23-000050
SEC(opens sec.gov)
Feb 34
Lawley Lori D0001126234-23-000015
SEC(opens sec.gov)

Companies

LUMOS PHARMA, INC.Chief Financial Officer

Address

C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DR.

AMES, IA, 50010